The Centers for Disease Control and Prevention rolled out the second installment of its four-part online training course tied to antibiotic stewardship on Monday. Two more segments are set to follow ...

Long-term care providers constantly being cited for lapses in antibiotic stewardship should adopt antibiotic-use protocols to improve adherence to federal infection control guidelines, according to a ...

More hospitals are operating antibiotic stewardship programs that meet all CDC standards, according to a new report from the agency. The CDC report summarizes new data and improvement efforts the ...

A CDC study published in JAMA Internal Medicine on Monday found that primary care providers are prescribing antibiotics for sinus infections longer than recommended by clinical practice guidelines. A ...

Roughly 60 percent of U.S. antibiotic use in humans is received in outpatient settings, according to the CDC, making that care setting critically important in the fight against antibiotic resistance.

The National Quality Forum, the CDC and Nashville, Tenn.-based Hospital Corporation of America led a team of experts to create a guide for hospitals of all sizes on how to implement an antibiotic ...

The COVID-19 pandemic has presented both challenges and opportunities. Antibiotic stewardship is a set of commitments and actions to optimize the treatment of infections, protect patients from harms ...

Skilled nursing facilities need more help from experts and their own staffs to become better stewards of antibiotic use, according to a new Centers for Disease Control and Prevention resource guide.

Healthcare providers that adopt a leadership model of drug stewardship can reduce the inappropriate use of antibiotics in hospitals, says the CDC. More than half of all hospital patients receive an ...

Credit: Getty Images Guillermo (Memo) Sanchez, PA-C, MPH, MSHS, discusses how antibiotic stewardship tracks antibiotic prescribing and improves appropriate use, reduces unnecessary use, and ensures ...

DUBLIN, Ireland, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective ...